These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 3937535

  • 1. Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia.
    Koizumi J, Mabuchi H, Yoshimura A, Michishita I, Takeda M, Itoh H, Sakai Y, Sakai T, Ueda K, Takeda R.
    Atherosclerosis; 1985 Dec; 58(1-3):175-86. PubMed ID: 3937535
    [Abstract] [Full Text] [Related]

  • 2. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.
    Riemens S, van Tol A, Sluiter W, Dullaart R.
    Atherosclerosis; 1998 Sep; 140(1):71-9. PubMed ID: 9733217
    [Abstract] [Full Text] [Related]

  • 3. Decreased serum cholesteryl-ester transfer activity in a patient with familial hyperalphalipoproteinemia.
    Takegoshi T, Haba T, Kitoh C, Tokuda T, Mabuchi H.
    Jpn J Med; 1988 Aug; 27(3):295-9. PubMed ID: 3193660
    [Abstract] [Full Text] [Related]

  • 4. Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer.
    Matsuzawa Y, Yamashita S, Funahashi T, Yamamoto A, Tarui S.
    Am J Cardiol; 1988 Jul 25; 62(3):66B-72B. PubMed ID: 3394656
    [Abstract] [Full Text] [Related]

  • 5. Increased plasma apolipoprotein E-rich high-density lipoprotein and its effect on serum high-density lipoprotein cholesterol determination in patients with familial hyperalphalipoproteinemia due to cholesteryl ester transfer activity deficiency.
    Chiba H, Eto M, Fujisawa S, Akizawa K, Intoh S, Miyata O, Noda K, Matsuno K, Kobayashi K.
    Biochem Med Metab Biol; 1993 Feb 25; 49(1):79-89. PubMed ID: 8439452
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels.
    Miettinen HE, Gylling H, Tenhunen J, Virtamo J, Jauhiainen M, Huttunen JK, Kantola I, Miettinen TA, Kontula K.
    Arterioscler Thromb Vasc Biol; 1998 Apr 25; 18(4):591-8. PubMed ID: 9555865
    [Abstract] [Full Text] [Related]

  • 9. Human plasma CETP deficiency: identification of a novel mutation in exon 9 of the CETP gene in a Caucasian subject from North America.
    Teh EM, Dolphin PJ, Breckenridge WC, Tan MH.
    J Lipid Res; 1998 Feb 25; 39(2):442-56. PubMed ID: 9508004
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Marked elevation in serum apolipoprotein E in a case of heterozygous cholesteryl ester transfer protein deficiency.
    Hirayama S, Kobayashi J, Taira K, Hikita M, Bujo H, Morisaki N, Matsunaga A, Sasaki J, Saito Y.
    Clin Chim Acta; 2000 Nov 25; 301(1-2):55-64. PubMed ID: 11020462
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A family of homozygous familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity.
    Eto M, Miyata O, Noda K, Makino I.
    Artery; 1990 Nov 25; 17(4):202-12. PubMed ID: 2360880
    [Abstract] [Full Text] [Related]

  • 14. Plasma lipoprotein abnormalities in heterozygotes for familial lecithin:cholesterol acyltransferase deficiency.
    Frohlich J, McLeod R, Pritchard PH, Fesmire J, McConathy W.
    Metabolism; 1988 Jan 25; 37(1):3-8. PubMed ID: 3121980
    [Abstract] [Full Text] [Related]

  • 15. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.
    Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, Maruhama Y, Mabuchi H, Tall AR.
    N Engl J Med; 1990 Nov 01; 323(18):1234-8. PubMed ID: 2215607
    [Abstract] [Full Text] [Related]

  • 16. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes.
    Dullaart RP, Hoogenberg K, Riemens SC, Groener JE, van Tol A, Sluiter WJ, Stulp BK.
    Diabetes; 1997 Dec 01; 46(12):2082-7. PubMed ID: 9392500
    [Abstract] [Full Text] [Related]

  • 17. Rate of cholesteryl ester transfer between high and low density lipoproteins in human serum and a case with decreased transfer rate in association with hyperalphalipoproteinemia.
    Kurasawa T, Yokoyama S, Miyake Y, Yamamura T, Yamamoto A.
    J Biochem; 1985 Dec 01; 98(6):1499-508. PubMed ID: 3867663
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Familial lecithin-cholesterol acyltransferase deficiency: biochemical characteristics and molecular analysis of a new LCAT mutation in a Polish family.
    Idzior-Waluś B, Sieradzki J, Kostner G, Małecki MT, Klupa T, Wesołowska T, Rostworowski W, Hartwich J, Waluś M, Kieć AD, Naruszewicz M.
    Atherosclerosis; 2006 Apr 01; 185(2):413-20. PubMed ID: 16051254
    [Abstract] [Full Text] [Related]

  • 20. Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia.
    Durrington PN, Mackness MI, Bhatnagar D, Julier K, Prais H, Arrol S, Morgan J, Wood GN.
    Atherosclerosis; 1998 May 01; 138(1):217-25. PubMed ID: 9678787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.